The President's Malaria Initiative: Bringing Effective Malaria Medicines to Angola

The Government of Angola declared an artemisinin-containing combination treatment (ACT), Coartem®, as its first-line malaria treatment because of the high levels of resistance to traditional antimalarial monotherapies, but it faced several challenges in getting the new medicines into its health facilities. By developing close working relationships among its partners, including PMI, RPM Plus, WHO, the Global Fund, and Angola’s Essential Medicines Program, and by improving its own leadership capabilities, the National Malaria Control Program has made significant progress in overcoming these challenges.

For the full story, please visit the PMI website here.

The above material was developed for PMI and is posted with the permission of PMI